Hikma Pharmaceutical | HIK - Operating Profit

Stock Price
1,259.50
Daily Change
-28.50 -2.21%
Monthly
-23.20%
Yearly
-39.45%
Q1 Forecast
1,214.21

Hikma Pharmaceutical reported $348M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Almirall EUR 30.23M 12.8M Dec/2025
argenx SE USD 371.14M 21.17M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Autolus Therapeutics Ltd USD -71.62M 10.99M Sep/2025
Bayer EUR 1.11B 1.65B Dec/2025
Fresenius EUR 713M 139M Dec/2025
Galapagos EUR 780.56M 822.23M Dec/2025
Genmab DKK 360M 172M Jun/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 275.38M 76.74M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Lonza CHF 430M 104M Dec/2024
Merck EUR 474M 738M Dec/2025
Orion EUR 328.2M 207.2M Dec/2025
Recordati EUR 278.23M 112.58M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 1B 678M Dec/2024